Jennifer Berres - Feb 13, 2025 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
SVP & Chief Human Res. Officer
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Stock symbol
HCA
Transactions as of
Feb 13, 2025
Transactions value $
-$3,206,262
Form type
4
Date filed
2/18/2025, 07:28 PM
Previous filing
Feb 11, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Award $0 +1.59K +6.68% $0.00 25.4K Feb 13, 2025 Direct F1
transaction HCA Common Stock Tax liability -$131K -407 -1.61% $321.92 24.9K Feb 13, 2025 Direct
transaction HCA Common Stock Sale -$1.34M -4.16K -16.66% $322.96 20.8K Feb 14, 2025 Direct F2
transaction HCA Common Stock Sale -$1.73M -5.38K -25.87% $322.31 15.4K Feb 14, 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 28, 2022, the reporting person was granted 3,060 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $322.71 to $323.28, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $321.70 to $322.69, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.